BR100 Increased By (0.9%)
BR30 Increased By (1.15%)
KSE100 Increased By (0.92%)
KSE30 Increased By (1%)
AGHA 6.39 Increased By ▲ 0.01 (0.16%)
BECO 4.36 Increased By ▲ 0.01 (0.23%)
BML 63.00 Increased By ▲ 0.45 (0.72%)
BOP 31.46 Increased By ▲ 0.07 (0.22%)
CNERGY 11.80 Increased By ▲ 0.07 (0.6%)
CSIL 5.79 Decreased By ▼ -0.12 (-2.03%)
FCCL 61.88 Increased By ▲ 0.17 (0.28%)
FFL 14.88 Increased By ▲ 0.09 (0.61%)
FNEL 1.29 Increased By ▲ 0.05 (4.03%)
KEL 6.34 Increased By ▲ 0.02 (0.32%)
KOSM 5.82 Decreased By ▼ -0.08 (-1.36%)
LOTCHEM 24.80 Increased By ▲ 0.11 (0.45%)
MLCF 106.70 Increased By ▲ 2.77 (2.67%)
NBP 174.50 Increased By ▲ 1.18 (0.68%)
NCPL 52.49 Increased By ▲ 0.66 (1.27%)
NPL 54.68 Increased By ▲ 0.65 (1.2%)
OGDC 320.25 Increased By ▲ 4.38 (1.39%)
PACE 9.28 Increased By ▲ 0.02 (0.22%)
PAEL 35.89 Increased By ▲ 0.31 (0.87%)
PIBTL 14.29 Increased By ▲ 0.63 (4.61%)
PPL 230.95 Increased By ▲ 4.88 (2.16%)
PRL 81.64 Increased By ▲ 1.36 (1.69%)
PTC 46.95 Increased By ▲ 0.31 (0.66%)
SSGC 24.25 Increased By ▲ 0.43 (1.81%)
TBL 9.25 Increased By ▲ 0.01 (0.11%)
TELE 7.63 Increased By ▲ 0.08 (1.06%)
TPL 24.80 Increased By ▲ 0.26 (1.06%)
TPLP 12.96 Decreased By ▼ -0.03 (-0.23%)
TREET 26.02 Increased By ▲ 0.04 (0.15%)
TRG 53.75 Increased By ▲ 0.42 (0.79%)

In a key development for Pakistan’s pharmaceutical sector, Citi Pharma Limited (CPHL) announced on Thursday that it had completed its first-ever export to the MENA region worth EUR 560,000.

“This export order was received on the basis of the FDA accreditation that Citi Pharma has obtained (announced on 20th September 2024),” the pharmaceutical shared the development in a notice to the Pakistan Stock Exchange (PSX) today.

It said that the total export value was EUR 560,000, of which it had previously received an advance payment of EUR 200,000.

“Today we have received the remaining balance of EUR 360,000, finalizing this initial export transaction.”

Pakistan’s Citi Pharma, Martin Dow partner with Chinese firm for biotech manufacturing

It added that overall, CPHL is eyeing a total export value of at least EUR 8,000,000 to EUR 10,000,000 annually to the MENA region and a similar amount to other international markets including North America.

The company stated that the achievement paves the way for Citi Pharma Limited’s growth in international markets, “strengthening our presence and unlocking new opportunities for the company”.

“We remain committed to growth and increasing shareholder value and will keep the shareholders informed,” the CPHL concluded.

Earlier in February, CPHL decided to venture into the real estate sector with the formation of Citi REIT Management Company, its wholly owned subsidiary.

CPHL’s board also gave its approval for setting up an antibiotic plant for the formulation section.

Furthermore, the company back then shared that it was also engaging in discussions on the formation of a joint venture with international partners for the development of a hospital.

Comments

Comments are closed for this article.

Imran Feb 27, 2025 02:46pm
welldone
0
monalisa Feb 28, 2025 06:32pm
good initiative.
0
NAVEED Feb 28, 2025 07:01pm
For Quality products sky is the limit Alhamdolilah
0